The epicenter of Clinical Strategy

The Clinical Strategy Track is a 2-day dedicated program (November 10–11, 2026) within BIO-Europe, focused on leading global clinical trial strategies, AI-driven innovation, and operational excellence.

Key themes include:

• Global expansion (China, APAC, MENA, Eastern Europe)
• Regulatory navigation (FDA, EU CTR updates)
• AI and decentralized trials
• Patient-centric recruitment (rare diseases, retention)
• Operational efficiency (site optimization, feasibility)

This brand new track delivers actionable strategies for senior clinical leaders with sessions on AI implementation, emerging-market entry, and adaptive trial designs - supported by real world case studies.

The clinical development landscape is undergoing rapid transformation, with AI-driven trial design, major global shifts in regulations and investment, and patient-centric approaches redefining how therapies advance.

BIO-Europe’s Clinical Strategy track will give biotech innovators and their partners critical insights for designing efficient clinical studies and making smarter, faster decisions about:

• Global trial execution: Where to run studies for optimal patient access, speed, and cost efficiency
• Regulatory strategy: How to align with evolving EU and international requirements
• Partnering with CROs and sites: Building the right alliances early to de-risk development

The Clinical Strategy track ensures that partnerships are built on clinically viable foundations from the outset. Unlock efficiencies and resources that can support faster clinical research and strengthen your partnership prospects.

This track is essential for leaders responsible for defining clinical strategy, driving operational excellence and accelerating market access:

• Biotech CEOs, CMOs, COOs, CSOs and CIOs driving clinical strategy for pipeline assets
• Clinical Development VPs/SVPs overseeing trial design and global expansion
• Investors assessing clinical feasibility in due diligence
• Business Development teams structuring deals with trial execution in mind
• CRO leadership optimizing site networks and patient recruitment

If your role involves top level clinical decision-making, partnership strategy, or trial execution, this content is for you.

This is the only event where clinical strategy is discussed through the lens of global deals, investment, and commercialization - not just trial logistics.

The Clinical Strategy Track at BIO-Europe stands apart by bridging clinical execution with deal-making - unlike traditional clinical conferences focused solely on operations. It uniquely integrates investors, biotechs, and CROs in strategic discussions, ensuring clinical feasibility is embedded in partnerships from the start. Designed for biotechs scaling trials and their partners, it connects attendees to BIO-Europe’s global network of leaders and innovators, setting the stage for transformative discussions that deliver global impact. This is where science meets actionable clinical strategy, all within Europe's largest biotech networking event.

Expect practical insights that drive trial success and strengthen partnerships:

• Designing investor-ready trials – Structure protocols with built-in feasibility and regulatory alignment to attract funding
• Transforming CRO collaborations – Shift from transactional relationships to strategic co-development of trial execution plans
• Learning from real-world trial challenges – Insights on avoiding common pitfalls in patient recruitment and site activation
• Navigating emerging markets confidently – Proven approaches for efficient site selection and enrolment in Asia and high-growth regions
• Implementing AI-driven efficiencies – Practical applications for optimizing protocols and accelerating trial timelines
• Building clinical-stage value – Strategies to position assets for successful funding rounds through execution expertise

The Clinical Strategy track is an in-person event track, taking place at BIO-Europe on November 10–11, 2026 in Cologne. You can attend the Clinical Strategy track as part of a 3-day content-only pass or a full partnering pass:

• November 9, 2026: The Big Picture plenary sessions + choose your sessions from Partnering & Investment, Therapeutic Insights and Ecosystem Innovation tracks
• November 10, 2026: Clinical Strategy Track
• November 11, 2026: Clinical Strategy Track

Content-only and All Access Partnering Pass attendees will gain access to all live panel discussions, fireside chat and content sessions across these 7 tracks over the 3 days:

• Strategic Clinical Strategy
• The Big Picture
• The Business of Biotech
• Regulatory Strategy
• Therapeutic Insights
• Biomanufacturing Strategy
• Ecosystem Innovation

Yes, BIO-Europe brings together 8000+ participants from across the global biopharma ecosystem, including C-level executives and clinical leadership from pharma and biotech, CROs, CDMOs, technology providers and investors, providing an excellent opportunity for networking. The Clinical Strategy program includes panel discussions, fireside chats and plenary sessions specifically designed to help you exchange insights, explore new opportunities and form lasting connections with like-minded professionals - and access to 6 other conference tracks throughout the event.

Plus, additional networking opportunities:

• Content-only pass:
  • Exhibit Hall Reception on Monday, November 9.
  • Breakfast, lunch, snacks, coffee and other non-alcoholic beverages at the venue.
    
    
• All Access Partnering pass:
  • Access to the partneringONE® event platform starting 6 weeks prior to the event.
  • Instant scheduling of your accepted partnering meetings. Each scheduled meeting will be assigned to a meeting location onsite.
  • Submission of up to 150 requests per company for one-to-one meetings during the conference.
  • Access to all live and pre-recorded panel discussions and fireside chats with global thought-leaders of the industry.
  • Access to all networking and evening receptions.
  • Breakfast, lunch, snacks, coffee and other non-alcoholic beverages at the venue.